JNJ vs CVS
By Alex · Tickerpine
Johnson & Johnson vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CVS |
|---|---|---|
| Price | $271.22 | $89.13 |
| Market cap | $653.61B | $113.99B |
| P/E ratio | 31.5 | 23.5 |
| ROE | 25.74% | 6.21% |
| Profit margin | 21.48% | 1.18% |
| Revenue growth | 6.60% | 7.10% |
| Dividend yield | 1.98% | 2.98% |
| Beta | 0.23 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CVS in plain English
- JNJ is the bigger company — about 5.7× the market cap of CVS.
- CVS is cheaper on earnings (P/E 23.5 vs 31.5).
- JNJ earns a higher return on equity (26% vs 6%).
- CVS is growing revenue faster (7% vs 7%).
- CVS has the higher dividend yield (2.98% vs 1.98%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.